(Laughter) It's got to be philanthropic, because profits distract biotech, but it's basically got a 90 percent chance, I think, of succeeding in this.
(Risos) Tem de ser filantrópico, pois os lucros perturbam a biotecnologia, mas temos 90% de hipóteses de sermos bem sucedidos.